Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization
2017 ◽
Vol 31
(2)
◽
pp. 99-105
◽
Tariq Al-Debasi
◽
Abdulkareem Al-Bekairy
◽
Abdulmalik Al-Katheri
◽
Shmeylan Al Harbi
◽
Mahmoud Mansour
2016 ◽
Vol 36
(8)
◽
pp. 1413-1417
◽
Zuhair H. Peracha
◽
Philip J. Rosenfeld
Menglu Zhang
◽
Jiaqi Liu
◽
Gang Liu
◽
Zeyu Xing
◽
Ziqi Jia
◽
...
Zizhong Hu
◽
Xin Cao
◽
Lu Chen
◽
Yun Su
◽
Jiangdong Ji
◽
...
Ahmad A. Aref
◽
Ingrid U. Scott
◽
Paul C. VanVeldhuisen
◽
Jacquie King
◽
Michael S. Ip
◽
...
2018 ◽
Vol 125
(11)
◽
pp. e81-e82
◽
2018 ◽
Vol 125
(2)
◽
pp. 237-244
◽
Alessandro Invernizzi
◽
Vuong Nguyen
◽
Jennifer Arnold
◽
Stephanie Young
◽
Daniel Barthelmes
◽
...
2016 ◽
Vol 254
(8)
◽
pp. 1651-1652
◽
Salih Uzun
◽
Emre Pehlivan
2016 ◽
Vol 57
(4)
◽
pp. 1798
◽
Hyun Jin Shin
◽
Soo-Nyung Kim
◽
Hyewon Chung
◽
Tae-Eun Kim
◽
Hyung Chan Kim
2020 ◽
Vol 40
(6)
◽
pp. 1098-1109
Meiaad Khayat
◽
David M. Wright
◽
Jianlee Yeong
◽
Daniel Xu
◽
Christopher Donley
◽
...
2019 ◽
Vol 39
◽
pp. S162-S168
◽
Shinji Toshima
◽
Yuki Morizane
◽
Shuhei Kimura
◽
Fumio Shiraga
Close
Export Citation Format
Close
Share Document
Close